| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President | Chief Financial Officer
1 company
Pinto Joshua is a President at Neumora Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $276K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | NMRA Neumora Therapeutics, Inc. | President | Sell | 8,048 | $1.67 | $13,477.18 | -9.5% | -60.1% | +107.5% | |
| Aug 27, 2024 | NMRA Neumora Therapeutics, Inc. | Chief Financial Officer | Sell | 15,693 | $11.39 | $178,806.04 | -10.1% | -16.3% | -84.8% | |
| Aug 26, 2024 | NMRA Neumora Therapeutics, Inc. | Chief Financial Officer | Sell | 84,307 | $11.67 | $984,061.15 | -13.3% | -17.4% | -85.1% |